Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Heterogeneity of tumour necrosis factor production in renal cell carcinoma.

Waase I, Bergholz M, Iglauer A, Beissert S, Blech M, Schauer A, Krönke M.

Eur J Cancer. 1992;28A(10):1660-4.

PMID:
1389482
2.

Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization.

Beissert S, Bergholz M, Waase I, Lepsien G, Schauer A, Pfizenmaier K, Krönke M.

Proc Natl Acad Sci U S A. 1989 Jul;86(13):5064-8.

3.

Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.

Lee CT, Genega EM, Hutchinson B, Fearn PA, Kattan MW, Russo P, Reuter VE.

Urol Oncol. 2003 May-Jun;21(3):179-84.

PMID:
12810203
4.
5.

Frequent overexpression of vascular endothelial growth factor gene in human renal cell carcinoma.

Sato K, Terada K, Sugiyama T, Takahashi S, Saito M, Moriyama M, Kakinuma H, Suzuki Y, Kato M, Kato T.

Tohoku J Exp Med. 1994 Jul;173(3):355-60.

6.

Differential expression of activator protein-2 isoforms in renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Miyajima A, Horiguchi Y, Nakashima J, Marumo K, Mukai M, Murai M.

Urology. 2004 Jul;64(1):162-7.

PMID:
15245963
7.
8.

Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.

Griffith TS, Fialkov JM, Scott DL, Azuhata T, Williams RD, Wall NR, Altieri DC, Sandler AD.

Cancer Res. 2002 Jun 1;62(11):3093-9.

9.

Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.

Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M.

J Urol. 2008 Oct;180(4):1284-9. doi: 10.1016/j.juro.2008.06.036. Epub 2008 Aug 15.

PMID:
18707725
10.

Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact.

Hofmockel G, Riess S, Bassukas ID, Dämmrich J.

Eur Urol. 1997;31(4):478-84.

PMID:
9187911
11.

Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.

Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knüchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, Denzinger S, Hartmann A, Hammerschmied CG.

Oncogene. 2007 Aug 16;26(38):5680-91. Epub 2007 Mar 12.

PMID:
17353908
12.

Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.

Lidgren A, Bergh A, Grankvist K, Rasmuson T, Ljungberg B.

BJU Int. 2008 Feb;101(4):480-4. Epub 2007 Oct 8.

13.
14.

Analysis of CD44 isoform v10 expression and its prognostic value in renal cell carcinoma.

Li N, Tsuji M, Kanda K, Murakami Y, Kanayama H, Kagawa S.

BJU Int. 2000 Mar;85(4):514-8.

15.

Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.

Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A.

Oncol Rep. 2005 Sep;14(3):777-82.

PMID:
16077991
16.

Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.

Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

Clin Cancer Res. 2007 Dec 15;13(24):7388-93.

17.

A cytogenetic approach to the differential diagnosis of metastatic clear cell renal carcinoma.

Amo-Takyi BK, Handt S, Gunawan B, Hollweg HG, Füzesi L.

Histopathology. 1998 May;32(5):436-43.

PMID:
9639119
18.
19.

Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma.

Ishizaki H, Yano H, Tsuneoka M, Ogasawara S, Akiba J, Nishida N, Kojiro S, Fukahori S, Moriya F, Matsuoka K, Kojiro M.

Pathol Int. 2007 Oct;57(10):672-80.

PMID:
17803656
20.

Effects of TNF-alpha and retinoic acid on the proliferation of the clear cell and chromophilic types of human renal cell carcinoma in vitro.

Gerharz CD, Ramp U, Reinecke P, Ressler U, Dienst M, Marx N, Friebe U, Engers R, Pollow K, Gabbert HE.

Anticancer Res. 1996 Jul-Aug;16(4A):1633-41.

PMID:
8712681

Supplemental Content

Support Center